A calcineurin antagonist-free induction immunosuppression strategy for delayed graft function in renal transplantation.
Hong
J C
JC
Division of Immunology and Organ Transplantation, University of Texas-Houston, Houston, Texas, USA.
Kahan
B D
BD
D000704:Analysis of Variance; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002102:Cadaver; D065095:Calcineurin Inhibitors; D015331:Cohort Studies; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000401:mortality / Q000503:physiopathology / Q000517:prevention & control*; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007668:Kidney / Q000502:physiology; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D020123:Sirolimus / Q000627:therapeutic use*; D015996:Survival Rate
D000911:Antibodies, Monoclonal; D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D015375:Receptors, Interleukin-2; D016572:Cyclosporine; D020123:Sirolimus